OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - CLEMENTIA PHARMACEUTICALS IN ownership

CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 37 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$463,000,000
-30.4%
39,339
-10.3%
0.02%
+30.8%
Q1 2018$665,000,00043,8660.01%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$137,196,0001.64%
NEA Management Company, LLC 2,141,697$28,185,0001.32%
Birchview Capital, LP 68,000$895,0000.61%
DRIEHAUS CAPITAL MANAGEMENT LLC 823,879$10,842,0000.37%
Rock Springs Capital Management LP 345,000$4,540,0000.18%
SECTORAL ASSET MANAGEMENT INC 112,213$1,477,0000.16%
Baker Brothers Advisors 1,192,595$15,695,0000.12%
PFM Health Sciences, LP 322,732$4,247,0000.07%
Artal Group S.A. 200,000$2,632,0000.06%
Weiss Multi-Strategy Advisers LLC 153,001$2,013,0000.05%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders